Skip to content

Comparison of the effects of different volumes of ropivacaine in laparoscopic cholecystectomy with supra-arcuate Ligament Blocks

Comparison of the effects of different volumes of ropivacaine in laparoscopic cholecystectomy with Supra-Arcuate Ligament Block

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065524
Enrollment
Unknown
Registered
2022-11-08
Start date
2022-11-10
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cholecystitis?cholecystolithiasis

Interventions

Group A:30ml 0.3% ropivacaine for anterior lumbar quadratus block
Group B:25ml 0.3% ropivacaine for anterior lumbar quadratus block
Group C:20ml 0.3% ropivacaine for anterior lumbar quadratus block

Sponsors

The Second Hospital of Shadong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients undergoing laparoscopic cholecystectomy under general anaesthesia for cholecystitis and cholecystolithiasis; 2. Aged between 18 and 65 years; 3. 20kg/m2= 30kg/m2,weight between 50 and 90 kg; 4. ASA I-III,no serious underlying illnesn;

Exclusion criteria

Exclusion criteria: 1. those with contraindications to general anaesthesia; 2. severe cardiac, hepatic or renal disease; 3. history of psychiatric disorders or overdose of opioid analgesics; 4. long-term medications affecting blood pressure and heart rate; 5. electrolyte disturbances; 6. patients with a predicted difficult airway; 7. history of surgery and anaesthesia within 6 months; 8. patients with contraindications or complications of lumbar square muscle block, including coagulation disorders, local infection and local anaesthetic toxicity; 9. Conversion to open surgery; 10. Patients with prolonged preoperative poor glycaemic control and combined diabetes mellitus; 11. Patients with combined cortisolism and reduction of associated metabolic abnormalities; 12. Spinal deformities; 13. Previous retroperitoneal position surgery.

Design outcomes

Primary

MeasureTime frame
NRS score 24 hours after surgery;

Secondary

MeasureTime frame
magnitude of intraoperative haemodynamic fluctuations;perioperative opioid dosage;duration and total amount of first postoperative remedial analgesia;blocking plane;effective time;

Countries

China

Contacts

Public ContactXin Zhao

The Second Hospital of Shandong University

lujnzx@sohu.com+86 17660085551

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026